IM Cannabis Corp. (IMC)

imcannabis.com ; www.imcannabis.de

High-Tech Company
Public Company

(NASDAQ CM: IMCC)

TECH VERTICALS

AgriBiotech, AgriTech, Medical Cannabis

General Data

Sector	Agritech
Company Stage:	Revenue Growth
Established	2010
Number of Employees	95
Reg. Number:	abCDe

DESCRIPTION

IM Cannabis is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

TECHNOLOGY

Premium medical cannabis strains and oils.

ESTIMATED ANNUAL SALES

Year	Amount
2024	500
2023	490
2022	480
2021	470
2020	460
2019	450
2018	440
2017	430

	TARGET MARKETS
	Medical Cannabis patients, Doctors and pharmacies licensed to treat patients with medical cannabis.

	BUSINESS MODEL
	B2B

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
EA867D61-F0D4-E711-80DD-00155D0B832C		IM Cannabis Corp. (IMC)
	Subsidiary	eWave Group Ltd.	IM Cannabis Corp. (IMC)
	Group	eWave Ltd.	eWave Group Ltd.
1A828DCC-1F7A-E111-AC59-00155D32A403	Group	Wendimu Ltd.	eWave Group Ltd.	Acquired/Merged
327518EC-7B8C-E111-AD2F-00155D32A403	Group	Commbox Communication & Automation Ltd.	eWave Group Ltd.
86D11E2C-207A-E111-AC59-00155D32A403	Group	Ewave MD Ltd.	eWave Group Ltd.
54C86FE4-1F7A-E111-AC59-00155D32A403	Subsidiary	SoftWatch Ltd.	Ewave MD Ltd.	Acquired/Merged

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Law Firm
abC Defghij	Law Firm
abC Defghij	Accounting Firm
abC Defghij	Investment Bank

REMARKS

Date	Remark
17/03/2026	IM Cannabis signed an agreement to acquire Blackaxe Technologies, a Polish technology company specializing in advanced defense and intelligence solutions.
01/04/2021	Acquired Panaxia's pharmacy, distribution and logistics arm.
30/12/2020	Following the acquisition of Trichome Financial Corp, the Combined Company will maintain offices in Glil Yam, Israel and Toronto, Canada, and will operate under the IM Cannabis Corp. corporate name with common shares trading on the Canadian Securities Exchange under the ticker symbol “IMCC.”

CONTACT INFO

Expand / Collapse All

Main Address: Kibbutz Glil-Yam, Israel

Address	Beit Hakshatot St.
City	Kibbutz Glil-Yam
Country	Israel

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Bad Oldesloe, Germany - Adjupharm GmbH

Address	Lily-Braun-Straße 48
City	Bad Oldesloe
Country	Germany
Zip	23843

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Oren Shuster	CEO & Co-Founder
Mr. Richard Balla	CEO, German Operations
Mr. Asi Levi	CFO

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Chairman	CEO, SciSparc
abC Defghij	Board Member	CEO & Co-Founder, IMC
abC Defghij	Board Member	CEO & Partner, LIV Collection (Ewave Holdings)
abC Defghij	Board Member	CEO, Packer Quality Materials
abC Defghij	Board Member	CEO & Founder, L1 Systems
abC Defghij	Board Member	Owner, ASI Glasses
abC Defghij	Board Member	CEO, Jeff's Brands

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Reverse Merger

Nov. 05, 2019

Initial Revenues

abCDe

Public Offerings

Deal Date	Type of Offering	Exchange	Amount Raise	Valuation	Remarks
May. 10, 2021	Second Public Offering	NASDAQ CM	abCDe	abCDe
Mar. 01, 2021	Listing	NASDAQ CM	abCDe	abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Debt Financing

Jul. 09, 2025

Initial Revenues

abCDe

PIPE

Nov. 12, 2024

Initial Revenues

abCDe

Total offering of CAD 2.14m. Includes a concurrent debt settlement in the amount of CAD$0.76m (US$0.56m).

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Private Investor	abCDe	Includes Debt Settlement Shares in the sum of $0.56m and pre-funded warrants in the sum of $0.4m.
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Debt Financing

Oct. 13, 2023

Initial Revenues

abCDe

PIPE

Jan. 13, 2023

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Private Investor	abCDe	Round co-leader
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe	Round co-leader

PIPE

Aug. 19, 2022

Initial Revenues

abCDe

Closed in 2 Tranches, 24/8/2022 and 6/10/2022. Led by the Company's management team.

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Private Investor	abCDe	Round co-leader
abC Defghij	Private Investor	abCDe	Round co-leader
abC Defghij	Private Investor	abCDe

PIPE

Aug. 30, 2019

Initial Revenues

abCDe

First Round

May. 01, 2018

Initial Revenues

abCDe

	Acquisitions made by IMC

Acquired Company	Sector	Date	Amount	Remarks
abC Defghij	N/A	Jul. 28, 2021	abCDe
abC Defghij	N/A	Jul. 28, 2021	abCDe
abC Defghij	N/A	Mar. 31, 2021	abCDe	In exchange for shares. Upon completion of the transaction, MYM shareholders will hold approximately 14.5% of IMC shares. The transaction includes MYM's wholly owned subsidiary, Highland Grow.
abC Defghij	N/A	Dec. 30, 2020	abCDe	Upon the completion of the Transaction, IMC shareholders will own approximately 82% of the Combined Company and Trichome shareholders will own 18%.
abC Defghij	N/A	Mar. 15, 2019	abCDe	As part of its global expansion and penetration plan into the European market, IMC acquired 100% of Adjupharm’s issued and outstanding shares for €0.924m paid in cash.